STOCK TITAN

Spruce Biosciences Recognized as a Bay Area Best Place to Work

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Spruce Biosciences (Nasdaq: SPRB), a late-stage biopharmaceutical company, has been recognized as a Best Place to Work in 2024 by the San Francisco Business Times and Silicon Valley Business Journal. The accolade highlights Spruce's dedication to creating a mission-driven culture emphasizing trust, innovation, ownership, and diversity. CEO Javier Szwarcberg expressed pride in the employees' commitment, which underpins the company's efforts to develop therapies for endocrine and neurological disorders. The award was based on anonymous employee surveys from over 230 companies, evaluating factors such as collaborative culture, benefits, and management practices.

Positive
  • Spruce Biosciences recognized as Best Place to Work in 2024.
  • Focus on creating a mission-driven culture centered on trust, innovation, ownership, and diversity.
  • Recognition based on anonymous employee surveys, indicating high employee satisfaction and engagement.
  • Competitive edge in attracting and retaining top talent due to positive workplace culture.
Negative
  • Recognition itself does not directly translate to financial performance or stock value.
  • Potential cost implications in maintaining high employee satisfaction and comprehensive benefits.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, announced that the San Francisco Business Times and the Silicon Valley Business Journal have recognized the company as a Best Place to Work in 2024.

“We are thrilled to be named as a Best Place to Work in the Bay Area, which is a testament to our unwavering dedication to cultivating a mission-driven company culture underlying our core values of trust, innovation, ownership and diversity,” said Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, Spruce Biosciences. “Our team members are at the heart of our organization, and I’m immensely proud of their dedication and commitment to each other and our stakeholders. This recognition deepens our sense of purpose as we advance our efforts towards delivering transformative treatment options for underserved patient communities.”

Winning organizations were selected from over 230 competing Bay Area companies that have created exceptional workplaces that their employees value highly. The selection process was based on anonymous employee surveys with participation requirements and overall employee engagement score rankings. Applicants were evaluated and ranked across workplace factors and values, including collaborative culture, compensation and benefits offerings, other amenities, and management practice, according to the number of Bay Area employees.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need. Spruce is developing its product candidate, tildacerfont, an oral, second-generation CRF1 receptor antagonist, for the treatment of congenital adrenal hyperplasia (CAH), polycystic ovary syndrome (PCOS) and major depressive disorder (MDD). To learn more, visit www.sprucebio.com and follow us on X @Spruce_Bio, LinkedIn, Facebook and YouTube.

About 2024 Bay Area Best Places to Work

Best Places to Work is an innovative publication and awards program produced by the San Francisco Business Times and the Silicon Valley Business Journal. The survey was administered online by the employers and through a service provided by Quantum Workplace, our research partner. The rankings are numeric based on Quantum’s scoring process and determined by surveys that went directly to employees who answered a series of questions. By ranking companies and sharing best practices we facilitate idea sharing and help other companies learn from the best.

Media

Katie Beach Oltsik

Inizio Evoke Comms

(937) 232-4889

Katherine.Beach@inizioevoke.com

media@sprucebio.com

Investors

Samir Gharib

President and CFO

Spruce Biosciences, Inc.

investors@sprucebio.com

Source: Spruce Biosciences, Inc.

FAQ

Why was Spruce Biosciences recognized as a Best Place to Work in 2024?

Spruce Biosciences was recognized due to its mission-driven culture emphasizing trust, innovation, ownership, and diversity, based on anonymous employee surveys.

What factors contributed to Spruce Biosciences being named a Best Place to Work?

Factors included a collaborative culture, compensation and benefits offerings, amenities, and management practices.

How many companies competed for the Best Place to Work recognition in the Bay Area?

Over 230 companies competed for the recognition.

What is the stock symbol for Spruce Biosciences?

The stock symbol for Spruce Biosciences is SPRB.

Who is the CEO of Spruce Biosciences?

The CEO of Spruce Biosciences is Javier Szwarcberg.

Spruce Biosciences, Inc.

NASDAQ:SPRB

SPRB Rankings

SPRB Latest News

SPRB Stock Data

18.18M
41.30M
7.73%
48.64%
0.5%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO